769 related articles for article (PubMed ID: 17972610)
1. [Bisphosphonate-associated osteonecrosis of the jaws 1].
Allard RH; Lips P; Eekhoff EM; van Merkesteyn JP; van der Waal I
Ned Tijdschr Tandheelkd; 2007 Oct; 114(10):423-7. PubMed ID: 17972610
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates and bisphosphonate induced osteonecrosis.
Sawatari Y; Marx RE
Oral Maxillofac Surg Clin North Am; 2007 Nov; 19(4):487-98, v-vi. PubMed ID: 18088900
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates and osteonecrosis of the jaws: science and rationale.
Gutta R; Louis PJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):186-93. PubMed ID: 17448709
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonate-induced osteonecrosis of the jaw: a medical enigma?
Siddiqi A; Payne AG; Zafar S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):e1-8. PubMed ID: 19570696
[TBL] [Abstract][Full Text] [Related]
5. Management of patients on bisphosphonates and prevention of bisphosphonate-related osteonecrosis of the jaw.
Chu V; ;
Hawaii Dent J; 2008; 39(5):9-12; quiz 17. PubMed ID: 19189512
[TBL] [Abstract][Full Text] [Related]
6. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
[TBL] [Abstract][Full Text] [Related]
7. Jaw osteonecrosis associated with intravenous bisphosphonate: is incidence reduced after adoption of dental preventive measures?
Fusco V; Baraldi A; Loidoris A; Ciuffreda L; Galassi C; Goia F; Scoletta M; Berrone S; Benech A; Ortega C; Berruti A;
J Oral Maxillofac Surg; 2009 Aug; 67(8):1775. PubMed ID: 19615599
[No Abstract] [Full Text] [Related]
8. Bisphosphonates: a potential threat to your patients.
Dreiman BB
J Indiana Dent Assoc; 2005-2006 Winter; 84(4):4-9. PubMed ID: 16605211
[No Abstract] [Full Text] [Related]
9. Osteonecrosis in the jaws of patients who are using oral biphosphonates to treat osteoporosis.
Dello Russo NM; Jeffcoat MK; Marx RE; Fugazzotto P
Int J Oral Maxillofac Implants; 2007; 22(1):146-53. PubMed ID: 17340909
[No Abstract] [Full Text] [Related]
10. [Bisphosphonates (BP) and osteonecrosis of the jaws; continuous treatment with Bisphosphonates should be considered].
Mawatari T
Clin Calcium; 2010 Nov; 20(11):1743-7. PubMed ID: 21066910
[No Abstract] [Full Text] [Related]
11. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
Grant BT; Amenedo C; Freeman K; Kraut RA
J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
[TBL] [Abstract][Full Text] [Related]
12. [Bisphosphonate-associated osteonecrosis of the jaws. 3. Two case reports].
Schortinghuis J; Meijndert L; de Visscher JG; Witjes MJ
Ned Tijdschr Tandheelkd; 2007 Oct; 114(10):432-5. PubMed ID: 17972612
[TBL] [Abstract][Full Text] [Related]
13. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws.
Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons
J Oral Maxillofac Surg; 2007 Mar; 65(3):369-76. PubMed ID: 17307580
[No Abstract] [Full Text] [Related]
14. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
Assael LA
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonates, osteonecrosis of the jaw, and dental treatment recommendations.
Radfar L; Masood F
J Okla Dent Assoc; 2008; 99(7):28-9. PubMed ID: 18595621
[TBL] [Abstract][Full Text] [Related]
16. Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws.
Kunchur R; Need A; Hughes T; Goss A
J Oral Maxillofac Surg; 2009 Jun; 67(6):1167-73. PubMed ID: 19446200
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonate osteonecrosis of the jaws; an increasing problem for the dental practitioner.
McLeod NM; Davies BJ; Brennan PA
Br Dent J; 2007 Dec; 203(11):641-4. PubMed ID: 18065983
[TBL] [Abstract][Full Text] [Related]
18. Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws.
Dodson TB
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):44-52. PubMed ID: 19371814
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonates and oral pathology I. General and preventive aspects.
Ponte Fernández N; Estefania Fresco R; Aguirre Urizar JM
Med Oral Patol Oral Cir Bucal; 2006 Aug; 11(5):E396-400. PubMed ID: 16878067
[TBL] [Abstract][Full Text] [Related]
20. [Bisphosphonates and osteonecrosis of the jaws].
Urade M
Clin Calcium; 2007 Feb; 17(2):241-8. PubMed ID: 17272882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
